DUBLIN, July 25, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended June 30, 2019 and provide a business update prior to market open on Wednesday, July 31, 2019.

ATLANTA, July 25, 2019 CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at the InterContinental Boston Hotel.

NEW YORK, July 25, 2019 /PRNewswire/ -- A staggering report was recently released by the International Consortium of Investigative Journalists (ICIJ) indicating that

LOS ANGELES, July 25, 2019 /PRNewswire/ -- Wearing designer Luchy Manjarrés Cohen, Los Angeles-area resident Cynthia Murphy just rocked the catwalk at the

DENVER, July 25, 2019 /PRNewswire/ -- Cannabigerol (CBG) has long been recognized and studied for its anti-inflammatory and other beneficial properties.  Leading consumer products companies have wanted to create products with high CBG potency but to date have been unable to access its healing qualities from a consistent and reliable cGMP processor because most

SALT LAKE CITY, Utah, July 25, 2019 /PRNewswire/ -- Curza, a privately-held small-molecule drug development company focused on the discovery and development of novel therapeutics to address the high unmet need of multi-drug resistant bacterial infections, announced today that it has received a $5,250,000 investment from the REPAIR Impact Fun

CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that its Board of Directors has authorized and declared a special cash dividend of $20 million on the Company's common stock.The special dividend is payable on September 5, 2019 to stockhold

IRVINE, Calif., July 25, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the second quarter ended June 30, 2019 on

ENGLEWOOD, Colo., July 25, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced the progress to date in the Company's special protocol assessment (SPA) phase three clinical trial titled "A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults with P

SAN DIEGO, July 25, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the first subject has been dosed in the Phase 2